<!doctype html><html lang=zh-tw><head><meta charset=utf-8><meta name=description content="at: [[inbox]]
Rheumatology - Systemic Sclerosis - Fast Facts | NEJM Resident 360 Systemic sclerosis (SSc), also known as scleroderma, is an autoimmune disease characterized by vasculopathy and fibrosis of the skin and internal organs."><meta property="og:title" content><meta property="og:description" content><meta property="og:type" content="website"><meta property="og:url" content><meta property="og:image" content="https://og-ph6wrfvo1-htlin222.vercel.app/api/blog?templateTitle=Rheumatology - Systemic Sclerosis - Fast Facts | NEJM Resident 360"><title>Rheumatology - Systemic Sclerosis - Fast Facts | NEJM Resident 360</title><meta name=viewport content="width=device-width,initial-scale=1"><link rel="shortcut icon" type=image/png href=https://www.physician.tw//icon.png><link href=https://www.physician.tw/styles.720e2c4835986a3891d6eef3a55faa22.min.css rel=stylesheet><link href=https://www.physician.tw/styles/_light_syntax.86a48a52faebeaaf42158b72922b1c90.min.css rel=stylesheet id=theme-link><script src=https://www.physician.tw/js/darkmode.dfadb738e747a87e78c7144d7267f1bc.min.js></script>
<script src=https://www.physician.tw/js/util.6f22941e242efae60fd84e7c32e874fa.min.js></script>
<link rel=preload href=https://cdn.jsdelivr.net/npm/katex@0.15.1/dist/katex.min.css as=style onload='this.onload=null,this.rel="stylesheet"' integrity=sha384-R4558gYOUz8mP9YWpZJjofhk+zx0AS11p36HnD2ZKj/6JR5z27gSSULCNHIRReVs crossorigin=anonymous><script defer src=https://cdn.jsdelivr.net/npm/katex@0.15.1/dist/katex.min.js integrity=sha384-z1fJDqw8ZApjGO3/unPWUPsIymfsJmyrDVWC8Tv/a1HeOtGmkwNd/7xUS0Xcnvsx crossorigin=anonymous></script>
<script defer src=https://cdn.jsdelivr.net/npm/katex@0.15.1/dist/contrib/auto-render.min.js integrity=sha384-+XBljXPPiv+OzfbB3cVmLHf4hdUFHlWNZN5spNQ7rmHTXpd7WvJum6fIACpNNfIR crossorigin=anonymous></script>
<script defer src=https://cdn.jsdelivr.net/npm/katex@0.16.2/dist/contrib/copy-tex.min.js integrity=sha384-ww/583aHhxWkz5DEVn6OKtNiIaLi2iBRNZXfJRiY1Ai7tnJ9UXpEsyvOITVpTl4A crossorigin=anonymous></script>
<script async src=https://unpkg.com/@floating-ui/core@0.7.3></script>
<script async src=https://unpkg.com/@floating-ui/dom@0.5.4></script>
<script async src=https://www.physician.tw/js/popover.f03552ccb84d99ca615d1cfb9abde59e.min.js></script>
<script defer src=https://www.physician.tw/js/code-title.ce4a43f09239a9efb48fee342e8ef2df.min.js></script>
<script defer src=https://www.physician.tw/js/clipboard.2913da76d3cb21c5deaa4bae7da38c9f.min.js></script>
<script defer src=https://www.physician.tw/js/callouts.7723cac461d613d118ee8bb8216b9838.min.js></script>
<script>const SEARCH_ENABLED=!1,LATEX_ENABLED=!0,PRODUCTION=!0,BASE_URL="https://www.physician.tw/",fetchData=Promise.all([fetch("https://www.physician.tw/indices/linkIndex.02120ee5abce9b994b1487466af3b5e4.min.json").then(e=>e.json()).then(e=>({index:e.index,links:e.links})),fetch("https://www.physician.tw/indices/contentIndex.9f18a39adf67bd3802b91e1815e3fa91.min.json").then(e=>e.json())]).then(([{index:e,links:t},n])=>({index:e,links:t,content:n})),render=()=>{const e=new URL(BASE_URL),t=e.pathname,n=window.location.pathname,s=t==n;addCopyButtons(),addTitleToCodeBlocks(),addCollapsibleCallouts(),initPopover("https://www.physician.tw",!0);const o=document.getElementById("footer");if(o){const e=document.getElementById("graph-container");if(!e)return requestAnimationFrame(render);e.textContent="";const t=s&&!1;drawGraph("https://www.physician.tw",t,[{"/moc":"#4388cc"}],t?{centerForce:1,depth:-1,enableDrag:!0,enableLegend:!1,enableZoom:!0,fontSize:.5,linkDistance:1,opacityScale:3,repelForce:1,scale:1.4}:{centerForce:1,depth:1,enableDrag:!0,enableLegend:!1,enableZoom:!0,fontSize:.6,linkDistance:1,opacityScale:3,repelForce:2,scale:1.2})}var i=document.getElementsByClassName("mermaid");i.length>0&&import("https://unpkg.com/mermaid@9/dist/mermaid.esm.min.mjs").then(e=>{e.default.init({securityLevel:"loose",theme:"base"})})},init=(e=document)=>{addCopyButtons(),addTitleToCodeBlocks(),renderMathInElement(e.body,{delimiters:[{left:"$$",right:"$$",display:!0},{left:"$",right:"$",display:!1}],macros:{'’':"'"},throwOnError:!1})}</script><script type=module>
    import { attachSPARouting } from "https:\/\/www.physician.tw\/js\/router.9d4974281069e9ebb189f642ae1e3ca2.min.js"
    attachSPARouting(init, render)
  </script></head><body><div id=search-container><div id=search-space><input autocomplete=off id=search-bar name=search type=text aria-label=搜尋 placeholder="請輸入像是：hypertension 之類的來看沒有沒什麼有趣的🎳"><div id=results-container></div></div></div><script src=https://cdn.jsdelivr.net/npm/flexsearch@0.7.21/dist/flexsearch.bundle.js integrity="sha256-i3A0NZGkhsKjVMzFxv3ksk0DZh3aXqu0l49Bbh0MdjE=" crossorigin=anonymous defer></script>
<script defer src=https://www.physician.tw/js/full-text-search.e6e2e0c213187ca0c703d6e2c7a77fcd.min.js></script><div class=singlePage><header><h1 id=page-title><a href=https://www.physician.tw/>蜥蜴花園🦎🌱🪴🌲</a></h1><div class=spacer></div><div id=search-icon><p>搜尋</p><svg tabindex="0" aria-labelledby="title desc" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 19.9 19.7"><title id="title">搜尋圖示</title><desc id="desc">打開搜尋圖標</desc><g class="search-path" fill="none"><path stroke-linecap="square" d="M18.5 18.3l-5.4-5.4"/><circle cx="8" cy="8" r="7"/></g></svg></div><div class=darkmode><input class=toggle id=darkmode-toggle type=checkbox tabindex=-1>
<label id=toggle-label-light for=darkmode-toggle tabindex=-1><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" id="dayIcon" viewBox="0 0 35 35" style="enable-background:new 0 0 35 35"><title>明亮模式</title><path d="M6 17.5C6 16.672 5.328 16 4.5 16h-3C.672 16 0 16.672.0 17.5S.672 19 1.5 19h3C5.328 19 6 18.328 6 17.5zM7.5 26c-.414.0-.789.168-1.061.439l-2 2C4.168 28.711 4 29.086 4 29.5 4 30.328 4.671 31 5.5 31c.414.0.789-.168 1.06-.44l2-2C8.832 28.289 9 27.914 9 27.5 9 26.672 8.329 26 7.5 26zm10-20C18.329 6 19 5.328 19 4.5v-3C19 .672 18.329.0 17.5.0S16 .672 16 1.5v3C16 5.328 16.671 6 17.5 6zm10 3c.414.0.789-.168 1.06-.439l2-2C30.832 6.289 31 5.914 31 5.5 31 4.672 30.329 4 29.5 4c-.414.0-.789.168-1.061.44l-2 2C26.168 6.711 26 7.086 26 7.5 26 8.328 26.671 9 27.5 9zM6.439 8.561C6.711 8.832 7.086 9 7.5 9 8.328 9 9 8.328 9 7.5c0-.414-.168-.789-.439-1.061l-2-2C6.289 4.168 5.914 4 5.5 4 4.672 4 4 4.672 4 5.5c0 .414.168.789.439 1.06l2 2.001zM33.5 16h-3c-.828.0-1.5.672-1.5 1.5s.672 1.5 1.5 1.5h3c.828.0 1.5-.672 1.5-1.5S34.328 16 33.5 16zM28.561 26.439C28.289 26.168 27.914 26 27.5 26c-.828.0-1.5.672-1.5 1.5.0.414.168.789.439 1.06l2 2C28.711 30.832 29.086 31 29.5 31c.828.0 1.5-.672 1.5-1.5.0-.414-.168-.789-.439-1.061l-2-2zM17.5 29c-.829.0-1.5.672-1.5 1.5v3c0 .828.671 1.5 1.5 1.5s1.5-.672 1.5-1.5v-3C19 29.672 18.329 29 17.5 29zm0-22C11.71 7 7 11.71 7 17.5S11.71 28 17.5 28 28 23.29 28 17.5 23.29 7 17.5 7zm0 18c-4.136.0-7.5-3.364-7.5-7.5s3.364-7.5 7.5-7.5 7.5 3.364 7.5 7.5S21.636 25 17.5 25z"/></svg></label><label id=toggle-label-dark for=darkmode-toggle tabindex=-1><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" id="nightIcon" viewBox="0 0 100 100" style="enable-background='new 0 0 100 100'"><title>黑暗模式</title><path d="M96.76 66.458c-.853-.852-2.15-1.064-3.23-.534-6.063 2.991-12.858 4.571-19.655 4.571C62.022 70.495 50.88 65.88 42.5 57.5 29.043 44.043 25.658 23.536 34.076 6.47c.532-1.08.318-2.379-.534-3.23-.851-.852-2.15-1.064-3.23-.534-4.918 2.427-9.375 5.619-13.246 9.491-9.447 9.447-14.65 22.008-14.65 35.369.0 13.36 5.203 25.921 14.65 35.368s22.008 14.65 35.368 14.65c13.361.0 25.921-5.203 35.369-14.65 3.872-3.871 7.064-8.328 9.491-13.246C97.826 68.608 97.611 67.309 96.76 66.458z"/></svg></label></div></header><article><h1>Rheumatology - Systemic Sclerosis - Fast Facts | NEJM Resident 360</h1><p class=meta>最後更新於
Feb 23, 2023
<a href=https://github.com/htlin222/garden/tree/hugo/content/Rheumatology%20-%20Systemic%20Sclerosis%20-%20Fast%20Facts%20%20NEJM%20Resident%20360.md rel=noopener>🪚 編輯原始文件</a></p><ul class=tags></ul><p>at: <a class="internal-link broken">inbox</a></p><a href=#rheumatology---systemic-sclerosis---fast-facts--nejm-resident-360><h1 id=rheumatology---systemic-sclerosis---fast-facts--nejm-resident-360><span class=hanchor arialabel=Anchor># </span>Rheumatology - Systemic Sclerosis - Fast Facts | NEJM Resident 360</h1></a><p>Systemic sclerosis (SSc), also known as scleroderma, is an autoimmune disease characterized by vasculopathy and fibrosis of the skin and internal organs. SSc has a poor prognosis, and mortality risk is estimated anywhere between two- to fivefold higher than the general population. Most SSc-related deaths are due to complications of pulmonary fibrosis; pulmonary arterial hypertension; cardiac, renal, or gastrointestinal disease; and infections. There is no cure for any manifestation of SSc.</p><p>The American College of Rheumatology (ACR) has defined the following subsets of systemic sclerosis:</p><ul><li><p><strong>limited cutaneous****SSc (lcSSc)</strong> includes CREST syndrome (calcifications, Raynaud phenomenon, esophageal hypomotility, sclerodactyly, and telangiectasia)</p></li><li><p><strong>diffuse cutaneous****SSc (dcSSc)</strong></p></li><li><p><strong>SSc without skin involvement</strong> (or “systemic sclerosis sine scleroderma” [ssSSc])</p></li></ul><a href=#manifestations><h3 id=manifestations><span class=hanchor arialabel=Anchor># </span>Manifestations</h3></a><p>A range of systems can be affected by systemic sclerosis and are outlined in the following table:</p><table><thead><tr><th>System</th><th>Symptoms & Signs</th></tr></thead><tbody><tr><td>Skin</td><td>Scleroderma</td></tr></tbody></table><ul><li>lcSSc: typically restricted to hands, face, and neck</li><li>dcSSc: involves chest, abdomen, forearms, upper arms, and shoulders<br>Sclerodactyly<br>Telangiectasias |
| Musculoskeletal | Fibrosis around tendons and nerves, manifesting as:</li><li>arthralgia</li><li>tendinopathy</li><li>myalgia</li><li>neuropathy |
| Vascular | Raynaud phenomenon (occurs in almost all patients with SSc)<br>Abnormalities in nail-fold capillaries (seen with a dermatoscope or other similar device)<br>Digital ulcers |
| Gastrointestinal | Esophageal dysmotility<br>Wide-mouthed diverticula<br>Telangiectasias<br>Primary biliary cirrhosis |
| Renal | Mild-to-moderate proteinuria<br>Increased creatinine<br>Hypertension<br>Scleroderma renal crisis |
| Pulmonary | Interstitial lung disease<br>Pulmonary arterial hypertension<br>Pleuritis<br>Endobronchial telangiectasias |
| Cardiac | Cardiac fibrosis<br>Coronary artery disease<br>Pericarditis |</li></ul><p>Although not diagnostic for SSc, Raynaud phenomenon develops in almost all patients with SSc:</p><a href=#findings-in-patients-with-raynauds-phenomenon><h3 id=findings-in-patients-with-raynauds-phenomenon><span class=hanchor arialabel=Anchor># </span>Findings in Patients with Raynaud’s Phenomenon</h3></a><p><strong>Panel A shows the pallor phase and Panel B the cyanotic phase.<br>(Source: Raynaud’s Phenomenon. N Engl J Med 2016.)</strong></p><a href=#diagnosis><h3 id=diagnosis><span class=hanchor arialabel=Anchor># </span>Diagnosis</h3></a><p>There is no single test to confirm diagnosis of SSc. Rather, diagnosis depends on a combination of clinical, laboratory, and, in some cases, pathologic manifestations. In 2013, the ACR revised classification criteria for SSc. These guidelines are more sensitive for identifying early SSc and are useful for evaluating patients with possible SSc. Using this classification system, a score of 9 classifies a patient as having definite SSC.</p><a href=#acr-classification-criteria-for-ssc><h3 id=acr-classification-criteria-for-ssc><span class=hanchor arialabel=Anchor># </span>ACR Classification Criteria for SSc</h3></a><p><strong>(Source: 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative. Reproduced with permission.)</strong></p><p>Many antibodies are associated with the various manifestations of SSc. For a summary of the phenotypic characteristics and their autoantibody associations, see table 1, “ Phenotypic Characteristics and Their Autoantibody Associations in Scleroderma,” from Mayo Clinic Proceedings, “My Approach to the Treatment of Scleroderma.” </p><a href=#treatment><h3 id=treatment><span class=hanchor arialabel=Anchor># </span>Treatment</h3></a><p>Treatment varies depending on the patient’s clinical manifestations. Therapies are either immunomodulatory, target vascular function, or target specific symptoms (i.e., proton pump inhibitors for reflux).</p><p>For an outline of important management considerations, see table 2, “Management Principles,” from Mayo Clinic Proceedings, “My Approach to the Treatment of Scleroderma.”</p><a href=#current-available-treatments-for-ssc><h3 id=current-available-treatments-for-ssc><span class=hanchor arialabel=Anchor># </span>Current Available Treatments for SSc</h3></a><table><thead><tr><th>Indication</th><th>Therapy</th><th>Mechanism of Action</th></tr></thead><tbody><tr><td>Skin changes</td><td>Glucocorticoids (used cautiously due to potential link with renal crisis)</td><td>Anti-inflammatory</td></tr><tr><td>Immunosuppression</td><td></td><td></td></tr><tr><td>Methotrexate</td><td></td><td></td></tr><tr><td>Mycophenolate mofetil</td><td>Immunosuppression</td><td></td></tr><tr><td>Musculoskeletal changes</td><td>Glucocorticoids</td><td>Anti-inflammatory</td></tr><tr><td>Immunosuppression</td><td></td><td></td></tr><tr><td>Methotrexate</td><td></td><td></td></tr><tr><td>Leflunomide</td><td>Immunosuppression</td><td></td></tr><tr><td>Surgery for nerve entrapment</td><td>Reduction in pressure on nerve</td><td></td></tr><tr><td>Raynaud phenomenon</td><td>Avoidance of exposure to the cold</td><td>Prevents vasoconstriction</td></tr><tr><td>Topical nitrates</td><td>Promotes vasodilation</td><td></td></tr><tr><td>Calcium-channel blockers, especially dihydropyridine-type</td><td>Vasodilation</td><td></td></tr><tr><td>Iloprost</td><td>Synthetic analogue of prostacyclin (PGI<sub>2</sub>)</td><td></td></tr><tr><td>Digital ulceration</td><td>Aspirin</td><td>Antiplatelet agent</td></tr><tr><td>Sildenafil/tadalafil</td><td>Phosphodiesterase type 5 inhibitor (PDE5) inhibitor</td><td></td></tr><tr><td>Bosentan</td><td>Endothelial receptor antagonist</td><td></td></tr><tr><td>Gastrointestinal dysmotility</td><td>Metoclopramide</td><td></td></tr><tr><td>Erythromycin</td><td>Promotility agents</td><td></td></tr><tr><td>Reflux</td><td>Pantoprazole</td><td></td></tr><tr><td>Omeprazole</td><td>Proton pump inhibitor</td><td></td></tr><tr><td>Renal crisis</td><td>Ramipril</td><td></td></tr><tr><td>Perindopril</td><td>Angiotensin-converting–enzyme (ACE) inhibitor</td><td></td></tr><tr><td>Interstitial lung disease</td><td>Glucocorticoids</td><td>Anti-inflammatory</td></tr><tr><td>Immunosuppression</td><td></td><td></td></tr><tr><td>Cyclophosphamide</td><td></td><td></td></tr><tr><td>Mycophenolate mofetil</td><td>Immunosuppression</td><td></td></tr><tr><td>Pulmonary arterial hypertension</td><td>Supplemental oxygen</td><td>Improved cardiac and systemic oxygenation</td></tr><tr><td>Ambrisentan</td><td></td><td></td></tr><tr><td>Bosentan</td><td></td><td></td></tr><tr><td>Macitentan</td><td>Endothelial receptor antagonist</td><td></td></tr><tr><td>Riociguat</td><td>Stimulates soluble guanylate cyclase</td><td></td></tr><tr><td>Epoprostenol</td><td></td><td></td></tr><tr><td>Treprostinil</td><td>Synthetic prostacyclin analogue</td><td></td></tr><tr><td>Rapidly progressive SSc with risk of organ failure</td><td>Autologous hemopoietic stem-cell transplantation</td><td></td></tr><tr><td>Lung transplantation</td><td>Immunomodulatory</td><td></td></tr><tr><td>Resets immune system</td><td></td><td></td></tr></tbody></table><p><a class="internal-link broken">inbox</a></p></article><hr><div class=page-end id=footer><div class=backlinks-container><h3>↩️ 反向連結</h3><ul class=backlinks><li><a href=/all-list-of-resident360/ data-ctx="Rheumatology - Systemic Sclerosis - Fast Facts  NEJM Resident 360" data-src=/all-list-of-resident360 class=internal-link>all list of resident360</a></li></ul></div><div><script async src=https://cdn.jsdelivr.net/npm/d3@6.7.0/dist/d3.min.js integrity="sha256-+7jaYCp29O1JusNWHaYtgUn6EhuP0VaFuswhNV06MyI=" crossorigin=anonymous></script><h3>🤯互動圖</h3><div id=graph-container></div><style>:root{--g-node:var(--secondary);--g-node-active:var(--primary);--g-node-inactive:var(--visited);--g-link:var(--outlinegray);--g-link-active:#5a7282}</style><script src=https://www.physician.tw/js/graph.2d9e48dbe7ea47c0ef1c58296ce14448.js></script></div></div><div><div id=disqus_thread></div><script type=application/javascript>window.disqus_config=function(){},function(){if(["localhost","127.0.0.1"].indexOf(window.location.hostname)!=-1){document.getElementById("disqus_thread").innerHTML="Disqus comments not available by default when the website is previewed locally.";return}var t=document,e=t.createElement("script");e.async=!0,e.src="//physician.disqus.com/embed.js",e.setAttribute("data-timestamp",+new Date),(t.head||t.body).appendChild(e)}()</script><noscript>Please enable JavaScript to view the <a href=https://disqus.com/?ref_noscript>comments powered by Disqus.</a></noscript><a href=https://disqus.com class=dsq-brlink>comments powered by <span class=logo-disqus>Disqus</span></a></div><div id=contact_buttons><footer><p>本網站是由 Hsieh-Ting Lin 以❤️ 用 <a href=https://github.com/jackyzha0/quartz>Quartz</a>這個酷東西種出來🪴 , © 2023</p><ul><li><a href=https://www.physician.tw/>🏠首頁</a></li><li><a href=https://www.facebook.com/Tim.H.Lin>Facebook</a></li><li><a href=https://twitter.com/htlin222>Twitter</a></li><li><a href=https://github.com/htlin222>GitHub</a></li><li><a href=https://htlin.site>Blog</a></li><li><a href=https://medium.com/@hsieh-ting-lin>Medium</a></li></ul></footer></div></div></body></html>